Gossamer Bio, Inc.
GOSS
$0.16
-$0.01-3.38%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.96M | 13.80M | 13.29M | 11.49M | 9.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.96M | 13.80M | 13.29M | 11.49M | 9.89M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 16.96M | 13.80M | 13.29M | 11.49M | 9.89M |
| SG&A Expenses | 18.75M | 10.90M | 9.39M | 8.68M | 8.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 61.82M | 59.84M | 54.93M | 50.25M | 46.70M |
| Operating Income | -44.87M | -46.04M | -41.64M | -38.77M | -36.81M |
| Income Before Tax | -46.66M | -47.33M | -48.22M | -38.27M | -36.64M |
| Income Tax Expenses | -- | -88.00K | -- | -- | -- |
| Earnings from Continuing Operations | -46.66M | -47.24M | -48.22M | -38.27M | -36.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.66M | -47.24M | -48.22M | -38.27M | -36.64M |
| EBIT | -44.87M | -46.04M | -41.64M | -38.77M | -36.81M |
| EBITDA | -44.86M | -46.03M | -41.63M | -38.76M | -36.80M |
| EPS Basic | -0.20 | -0.21 | -0.21 | -0.17 | -0.16 |
| Normalized Basic EPS | -0.12 | -0.14 | -0.11 | -0.11 | -0.10 |
| EPS Diluted | -0.20 | -0.21 | -0.21 | -0.17 | -0.16 |
| Normalized Diluted EPS | -0.12 | -0.14 | -0.11 | -0.11 | -0.10 |
| Average Basic Shares Outstanding | 234.14M | 226.60M | 227.98M | 227.28M | 226.82M |
| Average Diluted Shares Outstanding | 234.14M | 226.60M | 227.98M | 227.28M | 226.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |